NASDAQ · Drug Manufacturers - Specialty & Generic
Lantheus Holdings Inc (LNTH)
$100.25
-0.14%
44
In band
Moving averages
SMA 200$84.92+18.05%
Company profile
Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$6.55B
P/E ratio23.98
EPS$4.18
Beta-0.034
Dividend yield0.00%
52-week high$111.86
52-week low$49.67
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 48
CGC
Canopy Growth Corporation
RSI 40
BFRI
Biofrontera Inc
RSI 45
TLRY
Tilray Brands Inc - Class 2
RSI 39
ACB
Aurora Cannabis Inc
RSI 56
BCRX
Biocryst Pharmaceuticals Inc
RSI 32
INM
InMed Pharmaceuticals Inc
RSI 39
ORGO
Organogenesis Holdings Inc - Class A
RSI 30
ZTS
Zoetis Inc - Class A
RSI 57
AQST
Aquestive Therapeutics Inc
RSI 52
RSI alerts for LNTH
Get an email the moment Lantheus Holdings Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 11:32 AM EDT